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development (Gollenberg et al., 2010). However, among girls with
higher concentrations of urinary Cd, blood lead levels were
inversely related to inhibin b levels.
The aims of this analysis were to: 1) determinewhether urinary
cadmium concentration differed by age and race/ethnicity in a
cohort of girls and 2) evaluate whether cadmium was associated
with the attainment of menarche and breast and pubic hair
development.
Methods: The GRowth and LifeStyle (GRLS) study is a cohort of 230
girls, ages 10 to 13 years at baseline, residing in the San Francisco
Bay Area. A total of 211 girls provided overnight urine specimens
and completed a baseline interview and self-assessment of breast
and public hair development andwere followed for up to two years
for the attainment of menarche. Cadmium and creatinine con-
centrations were measured using inductively-coupled plasma
mass spectrometry (ICP/MS). We used Cox regression to evaluate
whether cadmium was associated with age at menarche and cu-
mulative logit regression to evaluate whether cadmium was
associated with breast and pubic hair development.
Results: The baseline mean creatinine-adjusted cadmium concen-
tration was 0.24 mg/g creatinine (SD ¼ 0.11 mg/g) and was highest
among 10-year olds (0.29 mg/g creatinine) and decreased with
increasing age (mean among 13-year olds ¼ 0.23 mg/g; p-trend ¼
0.05). Chinese girls had higher cadmium levels than non-Hispanic
Whites (0.30 vs. 0.23 mg/g creatinine; p ¼ 0.006).
Girls with the highest unadjusted cadmium levels (¼ 0.4 vs.
<0.2 mg/L) were less likely to have attained menarche (hazard ratio
¼ 0.42; 95% conﬁdence interval ¼ 0.23-0.78) and have a high
Tanner stage of pubic hair development (odds ratio ¼ 0.24; 95%
conﬁdence interval ¼ 0.07-0.81). Breast development stage was
not associated with cadmium concentration.
Conclusions: These ﬁndings suggest that a higher Cd body burden
may delay androgenic development (the ﬁrst stage of puberty) and
menarche. This is consistent with evidence from animal studies
suggesting that Cd exposure may delay the onset of estrus.
Whether this is due to ovotoxicity, as proposed for animals, is
unknown at this time.
Sources of Support: This research was supported by the California
Breast Cancer Research Program (award no. 17IB-0016) and the
National Institutes of Health (award no. U54CA100949).21.
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Purpose: Many adolescents with high-risk sexual behaviors only
receive health care episodically in the emergency department (ED).
ED visits offer an opportunity to deliver brief interventions to
improve health, but no proven ED-based brief intervention to
reduce sexual risk behaviors exists. The study objectives were to 1)
assess feasibility of a novel intervention using National Research
Council criteria (effectiveness, efﬁciency, and satisfaction), and 2)
examine impact on attitudes and behaviors.Methods: In this cross-sectional pilot study, sexuallyactive patients
aged 14-19 years presenting to a Midwestern ED were recruited to
receive an intervention to reduce sexual risk behaviors. The inter-
vention, based on motivational interviewing (MI), included agenda
setting, exploration of behaviors, decisional balance exercise,
tailored feedback, and referral to the hospital-afﬁliated Adolescent
Clinic. Individually-tailored sessions offered provision of condoms,
prescriptions for emergency contraception, and/or testing for
sexually transmitted infections (STI). Participants completed a
survey and intervention at baseline, an immediate post-interven-
tion survey at Time 1, and a three-month phone follow-up survey at
Time 2. Surveys assessed sexual behaviors, attitudes and self-efﬁ-
cacy regarding condoms and birth control. Additional questions
included: demographics (baseline), satisfaction, and ﬁdelity mea-
sures (Time 1). Feasibility criteria were: 1) Subject rated interven-
tionist ﬁdelity toMI principles (Likert scale 1¼ stronglyagree to 4¼
strongly disagree), 2) Session duration (minutes), and 3) Subject
satisfaction (Likert scale 1 ¼ not at all to 5 ¼ very).
Results: Sixty-six subjects (96% of approached) completed the
screening with 24 (37%) qualifying for enrollment by reporting
previous sexual activity. Of those, 20 (83%) participated (mean age
16.2 years; 60% female). Subjects somewhat or strongly agreed that
the interventionist: 1) “was easy to talk to” (90%), 2) “was con-
cerned about me” (78%), 3) “understood me” (89%), 4) “treated me
like an equal” (89%), and 5) “did not push me into something I
wasn’t ready for” (80%). The mean duration was 15.7 minutes. All
subjects were fairly (20%) or very (80%) satisﬁed. One subject
tested positive for Chlamydia trachomatis and received treatment
at Adolescent Clinic. When offered, most (59%) accepted condoms
and 71% accepted a prescription for emergency contraception. Five
subjects kept appointments at Adolescent Clinic where additional
services were provided: STI testing (n ¼ 2), birth control pre-
scribed/administered (n ¼ 2), provision of condoms (n¼1), and
inﬂuenza vaccination (n ¼ 1). Fifteen subjects (75%) were reached
for 3-month follow-up. Among those reporting sex since enroll-
ment (n ¼ 6), 67% reported continued condom use at most recent
sex. There were positive trends in attitudes towards condoms and
birth control self-efﬁcacy.
Conclusions: This ED-based intervention was delivered with high
ﬁdelity and relative rapidity, and resulted in high satisfaction
among these sexually active adolescents. A considerable propor-
tion received health services essential for optimal sexual health.
Studies to assess efﬁcacy appear warranted.
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Purpose: Vaccine coverage rates are far lower for adolescents than
they are for younger children. Providers are more likely to deliver
recommended vaccines to adolescents at standard preventive
